Prolonged-time period cannabis consumers are at risk for developing cannabinoid hyperemesis syndrome (CHS), characterised by recurrent bouts of intense vomiting and abdominal cramping for the duration of or within forty eight hrs of heavy cannabis use.[108] The system at the rear of CHS is badly understood and it is contrary for the antiemetic Attr